MoneyAM MoneyAM
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Research   Share Price   Awards   Indices   Market Scan   Company Zone   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Stock Screener   Forward Diary   Forex Prices   Director Deals   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Videos   Comparison Tables   Spread Betting   Broker Notes   Shares Magazine 
You are NOT currently logged in

 
Filter Criteria  
Epic: Keywords: 
From: Time:  (hh:mm) RNS:  MonAM: 
To: Time:  (hh:mm)
Please Note - Streaming News is only available to subscribers to the Active Level and above
 


AIM WINNERS & LOSERS: Polarean Imagaing jumps on US FDA approval

ALN

The following stocks are the leading risers and fallers on AIM in London on Wednesday.

----------

AIM - WINNERS

----------

Polarean Imaging PLC, up 35% at 66.25 pence, 12-month range 37.28p - 84.20p. Secures approval from the US Food & Drug Administration for its drug device combination product, Xenoview, for evaluation of lung ventilation in adults and paediatric patients aged 12 years and older. Polarean Chief Executive Richard Hullihen says: ‘Approval of Xenoview represents a major step forward in modern respiratory imaging and we are proud to have pioneered this exciting new technology for clinical use. The commercial team at Polarean is prepared to rapidly launch Xenoview for clinical application.’

----------

Applied Graphene Materials PLC, up 9.7% at 5.49 pence, 12-month range 3.00p - 28.00p. Confirms that non-binding indicative proposals have been received from interested parties for the sale of its trade and assets, or of the shares in, its main operating subsidiary. Says it is in discussions with the parties involved with a view to gaining final proposals in early January. After this, the board would then select a preferred party to progress with. Adds there can be no certainty any final proposals will be made, nor the terms any proposals may be made.

----------

AIM - LOSERS

----------

Trafalgar Property Group PLC, down 4.9% at 0.16 pence, 12-month range 0.15p - 1.20p. Interim loss widens as revenue falls sharply and costs increase. In the six months to September 30, pretax loss widens to £444,000 from £338,000. Revenue drops to £18,000 from £390,000, and administrative expenses increase 48% to £380,000 from £257,000. Chief Executive Paul Treadaway says: ‘Reflecting on the issues of the previous two years in the economy and the challenges businesses and consumers have faced, the directors have considered relevant information including the current cost-of-living crisis, higher interest rates and even higher inflation, which are driving a challenging market and have performed a robust analysis of future cash flows.’

----------

By Heather Rydings, Alliance News senior economics reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2022 Alliance News Ltd. All Rights Reserved.